Neimeth International Pharmaceuticals Plc announced earnings results for the second quarter ended March 31, 2020. For the second quarter, the company announced sales was NGN 558.691 million compared to NGN 748.780 million a year ago. Operating income was NGN 28.585 million compared to NGN 160.264 million a year ago. Net loss was NGN 26.055 million compared to net income of NGN 144.476 million a year ago. Basic loss per share was NGN 0.0137 compared to basic earnings per share of NGN 0.0761 a year ago. For the half year, sales was NGN 1,165.166 million compared to NGN 975.982 million a year ago. Operating income was NGN 124.063 million compared to NGN 38.137 million a year ago. Net income was NGN 56.596 million compared to NGN 5.447 million a year ago. Basic earnings per share was NGN 0.0298 compared to NGN 0.0029 a year ago.